Latest news
Grace Therapeutics (GRCE): Opaleye reports 2.75M-share, 13.07% ownership stake - Stock TitanStock Titan · Fri, 07 Aug 2026 20:06:08 GMTGrace Therapeutics, Inc. (NASDAQ: GRCE) Share Price, GRCE Stock News, GRCE Share Price & Updates - KalkineKalkine · Fri, 07 Aug 2026 20:06:00 GMTGrace Therapeutics announces securities purchase agreement for $10M private placement - ROI-NJROI-NJ · Thu, 06 Aug 2026 14:12:11 GMTReCode Therapeutics Announces New Funding from the Cystic Fibrosis Foundation, Collaboration with a Leading Gene Editing Company and Leadership Transition - BioSpaceBioSpace · Thu, 06 Aug 2026 13:57:48 GMTGrace Therapeutics (GRCE) Advances Dual-Source Manufacturing Ami - GuruFocusGuruFocus · Wed, 05 Aug 2026 11:44:11 GMTGrace Therapeutics (GRCE) Raises $10M in Private Placement Amid High Price-to-Sales Valuation - GuruFocusGuruFocus · Wed, 05 Aug 2026 11:44:11 GMTGrace Therapeutics Expects Funding to Extend Cash Runway Through 2028 - Stock TitanStock Titan · Wed, 05 Aug 2026 03:43:14 GMTGrace Therapeutics Announces $10 Million Private Placement Financing to Support GTx-104 Development - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 01:10:00 GMT